![Hunter Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 12 M $ al 31/08/2026
Hunter C.
Smith is currently Director at Vanqua Bio, Inc. and Chief Financial Officer & Treasurer at Rhythm Pharmaceuticals, Inc. since 2021.
Former roles include Independent Director at Genesee & Wyoming, Inc. from 2015 to 2019, Independent Director at Spyre Therapeutics, Inc. from 2021 to 2023, Director-Commodities Finance at UBS AG (Stamford Branch) from 1992 to 1999, CFO-Inflammation & Immunology and VP-Finance at Celgene Corp.
from 2013 to 2017, Chief Financial Officer-Sugar & Bioenergy Segment at Bunge Ltd. from 2010 to 2013, and Credit Analyst at Manufacturers Hanover Corp.
from 1990 to 1992.
Education includes undergraduate studies at Northwestern University and an MBA from The Leonard N Stern School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/08/2026 | 114.024 ( 0,17 % ) | 12 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Director Financiero/CFO | 01/07/2017 |
Vanqua Bio, Inc.
 Vanqua Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that focused on developing novel therapies for Parkinson's disease | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Director/Miembro de la Junta | 22/11/2023 |
| GENESEE & WYOMING INC. | Director/Miembro de la Junta | 30/12/2019 |
| CELGENE | Corporate Officer/Principal | 01/07/2017 |
Bunge Ltd.
 Bunge Ltd. Agricultural Commodities/MillingProcess Industries Engages in the agriculture and food businesses | Public Communications Contact | 01/01/2003 |
UBS AG (Stamford Branch)
 UBS AG (Stamford Branch) Financial ConglomeratesFinance Provides financial and investment services | Corporate Officer/Principal | 01/01/1999 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Genesee & Wyoming, Inc.
 Genesee & Wyoming, Inc. RailroadsTransportation Provides rail freight transportation services | Transportation |
Bunge Ltd.
Bunge Ltd. Agricultural Commodities/MillingProcess Industries Engages in the agriculture and food businesses | Process Industries |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UBS AG (Stamford Branch)
UBS AG (Stamford Branch) Financial ConglomeratesFinance Provides financial and investment services | Finance |
Manufacturers Hanover Corp.
 Manufacturers Hanover Corp. Financial ConglomeratesFinance Operates as a bank holding company | Finance |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanqua Bio, Inc.
Vanqua Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that focused on developing novel therapies for Parkinson's disease | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
